been mulling this in my head for the last days:
1: the major deals are all based on a minimal cash lay out and and a long term repayment phase (based/or directly linked to future earning!)
2: they were negotiated with administrators; we are talking about serious bean counters that would not have given the go ahead if there was the slightest doubt about the purchasers not being able to come up with the money - their prof.integrety would be gone for ever
3: PB mentioned institutional interest: extremely unusual in a biotech/pharma penny stock - if there is interest (and PB is usually carefull with information he discloses) they have more "inside knowledge" than we have atm.
Wether you like PB or not - he seems to have an amazing long term vision for STI - and you can only admire him for that. He is also assembling a team around him that might just pull it off
Just thoughts - DYOR
Add to My Watchlist
What is My Watchlist?